Naomi Guppy

1.2k total citations
21 papers, 473 citations indexed

About

Naomi Guppy is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Naomi Guppy has authored 21 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Naomi Guppy's work include Cancer Cells and Metastasis (5 papers), Cancer Research and Treatments (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Naomi Guppy is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Cancer Research and Treatments (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Naomi Guppy collaborates with scholars based in United Kingdom, United States and Singapore. Naomi Guppy's co-authors include Malcolm Alison, Linda Nicholson, Susan Lim, Syed Haider, Andrea Gillespie, Clare M. Isacke, Frances K. Turrell, Chris Starling, Mairi Brittan and Tariq G. Fellous and has published in prestigious journals such as Nature, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Naomi Guppy

21 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naomi Guppy United Kingdom 14 188 182 94 88 82 21 473
Anne Tallet France 13 124 0.7× 238 1.3× 75 0.8× 177 2.0× 59 0.7× 37 566
Shenglin Li China 12 218 1.2× 146 0.8× 96 1.0× 81 0.9× 28 0.3× 52 627
David Cimbaluk United States 14 193 1.0× 82 0.5× 72 0.8× 112 1.3× 53 0.6× 33 536
Letizia Perracchio Italy 16 382 2.0× 315 1.7× 168 1.8× 110 1.3× 38 0.5× 33 801
Christopher Angel Australia 13 269 1.4× 363 2.0× 76 0.8× 94 1.1× 25 0.3× 31 663
A. Kyroudi Greece 13 231 1.2× 278 1.5× 89 0.9× 76 0.9× 39 0.5× 28 686
Jeff Kutok United States 6 226 1.2× 108 0.6× 50 0.5× 66 0.8× 52 0.6× 10 428
Julie Y. Tse United States 14 129 0.7× 173 1.0× 69 0.7× 60 0.7× 33 0.4× 40 446
Xihu Yang China 15 385 2.0× 214 1.2× 193 2.1× 65 0.7× 23 0.3× 35 716
S. Hsueh Taiwan 12 177 0.9× 133 0.7× 175 1.9× 85 1.0× 88 1.1× 39 618

Countries citing papers authored by Naomi Guppy

Since Specialization
Citations

This map shows the geographic impact of Naomi Guppy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Guppy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Guppy more than expected).

Fields of papers citing papers by Naomi Guppy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomi Guppy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Guppy. The network helps show where Naomi Guppy may publish in the future.

Co-authorship network of co-authors of Naomi Guppy

This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Guppy. A scholar is included among the top collaborators of Naomi Guppy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Guppy. Naomi Guppy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Huafu, Linxiang Lan, Hengxing Chen, et al.. (2025). SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. Nature. 648(8092). 203–209. 1 indexed citations
2.
Turrell, Frances K., Naomi Guppy, Andrea Gillespie, et al.. (2023). Age-associated microenvironmental changes highlight the role of PDGF-C in ER+ breast cancer metastatic relapse. Nature Cancer. 4(4). 468–484. 44 indexed citations
3.
Kim, Hyojin, et al.. (2021). Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells. Disease Models & Mechanisms. 14(5). 2 indexed citations
4.
Raza, Shan E Ahmed, Allison Hall, Jeffrey R. Marks, et al.. (2021). Unmasking the immune microecology of ductal carcinoma in situ with deep learning. npj Breast Cancer. 7(1). 19–19. 19 indexed citations
5.
Busacca, Sara, Laura O’Regan, Annabel Sharkey, et al.. (2020). BRCA1/MAD2L1 Deficiency Disrupts the Spindle Assembly Checkpoint to Confer Vinorelbine Resistance in Mesothelioma. Molecular Cancer Therapeutics. 20(2). 379–388. 13 indexed citations
6.
Smith, Henry, Jasbani H.S. Dayal, Tencho Tenev, et al.. (2020). RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma. EMBO Molecular Medicine. 12(6). e10979–e10979. 26 indexed citations
7.
8.
Caruana, Daren J., Dahmane Oukrif, Naomi Guppy, et al.. (2019). Rapid and complete paraffin removal from human tissue sections delivers enhanced Raman spectroscopic and histopathological analysis. The Analyst. 145(4). 1499–1510. 11 indexed citations
9.
Alrifai, Doraid, Krishna K. Kolluri, Elizabeth K. Sage, et al.. (2018). Retrospective response analysis of BAP1 expression to predict the clinical activity of systemic cytotoxic chemotherapy in mesothelioma. Lung Cancer. 127. 164–166. 12 indexed citations
10.
Brilha, Sara, et al.. (2018). Integrin α2β1 Expression Regulates Matrix Metalloproteinase-1-Dependent Bronchial Epithelial Repair in Pulmonary Tuberculosis. Frontiers in Immunology. 9. 1348–1348. 14 indexed citations
11.
Byng-Maddick, Rachel, Carolin T. Turner, Gabriele Pollara, et al.. (2017). Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF Therapy. Frontiers in Immunology. 8. 932–932. 9 indexed citations
12.
Chan, Anita Sook Yee, Hardeep Singh Mudhar, Sunny Shen, et al.. (2017). Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease (IgG4-RD): Potential use in IgG4-RD assessment.. British Journal of Ophthalmology. 101(11). 1576–1582. 36 indexed citations
13.
Guppy, Naomi, et al.. (2017). Multiple myeloma in an Amur tiger (<i>Panthera tigris altaica</i>). Open Veterinary Journal. 7(4). 300–300. 3 indexed citations
14.
Pollara, Gabriele, James Heather, Rachel Byng-Maddick, et al.. (2017). Validation of Immune Cell Modules in Multicellular Transcriptomic Data. PLoS ONE. 12(1). e0169271–e0169271. 13 indexed citations
15.
Guppy, Naomi, Martin Isabelle, Jennifer Dorney, et al.. (2017). Developing Raman spectroscopy as a diagnostic tool for label‐free antigen detection. Journal of Biophotonics. 11(2). 3 indexed citations
16.
Scheipl, Susanne, Lucia Cottone, Mette Jørgensen, et al.. (2016). EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen. The Journal of Pathology. 239(3). 320–334. 62 indexed citations
17.
AlGhamdi, Saleh, Abdulkader M. Albasri, Mohammed Ahmed, et al.. (2012). C-Terminal Tensin-Like Gene Functions as an Oncogene and Promotes Cell Motility in Pancreatic Cancer. Pancreas. 42(1). 135–140. 30 indexed citations
18.
Guppy, Naomi, Hemant M. Kocher, Yassar Qureshi, et al.. (2012). Trefoil Factor Family Peptides in Normal and Diseased Human Pancreas. Pancreas. 41(6). 888–896. 18 indexed citations
19.
Alison, Malcolm, Naomi Guppy, Susan Lim, & Linda Nicholson. (2010). Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?. The Journal of Pathology. 222(4). 335–344. 103 indexed citations
20.
Fellous, Tariq G., Naomi Guppy, Mairi Brittan, & Malcolm Alison. (2006). Cellular pathways to β‐cell replacement. Diabetes/Metabolism Research and Reviews. 23(2). 87–99. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Tallet Breakdown of academic impact, for papers by Shenglin Li Breakdown of academic impact, for papers by David Cimbaluk Breakdown of academic impact, for papers by Letizia Perracchio Breakdown of academic impact, for papers by Christopher Angel Breakdown of academic impact, for papers by A. Kyroudi Breakdown of academic impact, for papers by Jeff Kutok Breakdown of academic impact, for papers by Julie Y. Tse Breakdown of academic impact, for papers by Xihu Yang Breakdown of academic impact, for papers by S. Hsueh
Rankless by CCL
2026